Editor-in-Chief:

Jos H. Beijnen
The Netherlands Cancer Institute/Slotervaart Hospital
Amsterdam
The Netherlands

Editorial Advisory Board:

R. Agarwal (Indiana University School of Medicine, Indianapolis, IN, USA)
R. Agbaria (Ben-Gurion University of the Negev, Beer-Sheva, Israel)
H. Allain (University of Rennes, Rennes, France)
K. Allegaert (University Hospital, Leuven, Belgium)
T. Andersson (AstraZeneca LP, Wayne, PA, USA)
J. Ansell (Boston University School of Medicine, Boston, MA, USA)
S. Antila (National Agency for Medicines, Helsinki, Finland)
M. Anttila (Hormos Medical Corporation, Turku, Finland)
V.W. Armstrong (George-August University, Goettingen, Germany)
A. Awada (Jules Bordet Institute, Brussels, Belgium)
M. Azizi (European Hospital Georges Pompidou, Paris, France)
J. Azuma (Osaka University, Yamada-oka Suita, Japan)
A. Azzi (University of Bern, Bern, Switzerland)
S.D. Baker (The Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD, USA)
J.P. Balthasar (The State University of New York, Buffalo, NY, USA)
B. Bannwarth (Victor Segalen University, Bordeaux, France)
T. Baptista (Los Andes University Medical School, Merida, Venezuela)
J. Barnes (University of London, London, UK)
A. Basu (City Hospital, Birmingham, UK)
R. Bellmann (Innsbruck Medical School, Innsbruck, Austria)
E. Bergogne-Berezin (University of Paris, Paris, France)
M. Berkovitch (Assaf Harofeh Medical Centre, Zerifin, Israel)
J.M. Blondeau (Royal University Hospital, Saskatchewan, Canada)
J. Boni (Wyeth Research, Collegeville, PA, USA)
D.W. Boulton (Bristol-Myers Squibb Pharmaceut. Res. Inst., Princeton, NJ, USA)
P. Boutouyrie (Hôpital Européen Georges, Pompidou, France)
F. Bressolle (University of Montpellier, Montpellier, France)
C. Brink (North-West University, Potchefstroom, South Africa)
M. Brown (Austin and Repatriation Medical Centre, Victoria, Australia)
K. Budde (Charite University Hospital, Berlin, Germany)
D.M. Burger (University Medical Center Nijmegen, Nijmegen, The Netherlands)
J.A.L. Calbet (Univ. de Las Palmas de Gran Canaria, Canary Islands, Spain)
M.A. Campanero (University of Navarra, Pamplona, Spain)
D. Cattaneo (Mario Negri Institute for Pharmacological Research, Ranica, Italy)
H.-K. Chan (University of Sydney, Sydney, Australia)
E. Chatelut (Institut Claudius-Regaud, Toulouse, France)
A.K. Chaturvedi (FAA Civil Aerospace Med. Inst., Oklahoma, OK, USA)
E. Chen (Princess Margaret Hospital, Toronto, Canada)
T. Choueiri (The Cleveland Clinic Foundation, Cleveland, OH, USA)
B. Chowbay (National Cancer Centre, Singapore, Singapore)
S.G. Chrysant (University of Oklahoma, Oklahoma, OK, USA)
H. Chrystyn (University of Bradford, Yorkshire, UK)
S. Cisternino (Hospital F. Widal, Paris, France)
T.J. Cleophas (Albert Schweitzer Hospital, Dordrecht, The Netherlands)
S. Cox (University of Tennessee, Knoxville, TN, USA)
S. Cremers (Novartis Pharmaceutical Corporation, Florham Park, NJ, USA)
C.C. Crone (Inova Fairfax Hospital, Falls Church, VA, USA)
A. Dahan (Leiden University Medical Center, Leiden, The Netherlands)
M-L. Dahl (Karolinska University Hospital, Stockholm, Sweden)
E. Dailly (University Hospital of Nantes, Nantes, France)
P.T. Daley-Yates (Clinical Pharmacology and Discovery Medicine, Greenford, UK)
A.K. Daly (University of Newcastle Medical School, Newcastle Upon Tyne, UK)
A. Dasgupta (University of Texas-Houston Medical School, Houston, TX, USA)
E. David-Neto (University of Sao Paulo School of Medicine, Sao Paulo, Brazil)
M. Davidson (Radiant Research, Chicago, IL, USA)
N.M. Davies (Washington State University, Pullman, WA, USA)
A. Dawidowicz (Maria Curie-Sklodowska University, Lublin, Poland)
D. de Alwis (Eli Lilly & Company Ltd., Surrey, UK)
M. del Tacca (University of Pisa, Pisa, Italy)
R. de la Torre (Institut Municipal d'Investigació Mèdica, Barcelona, Spain)
J. de Leon (University of Kentucky, Lexington, KY, USA)
J.E. Dennison (Colorado State University, Fort Collins, CO, USA)
G. Derosa (University of Pavia, Pavia, Italy)
C.L. DeVane (Medical University of South Carolina, Charleston, SC, USA)
J. Dingemanse (Actelion Pharmaceuticals Ltd., Allschwil, Switzerland)
S.A. Doggrell (Auckland University of Technology, Auckland, New Zealand)
G. Dollo (University of Rennes I, Rennes, France)
J.G. Donnelly (New York University School of Medicine, New York, NY, USA)
M. Dooley (Bayside Health, Victoria, Australia)
P. Dorado (Extremadura University Hospital, Badajoz, Spain)
D. Drover (Stanford University, Stanford, CA, USA)
E.F.L. Dubois (Reinier de Graaf Groep Delft-Voorburg, Voorburg, The Netherlands)
J. Duconge (University of Turabo, Gurabo, PR, USA)
J.B. Dumond (UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA)
S. Dutta (Abbott Laboratories, Abbott Park, IL, USA)
C.B. Eap (Hospital de Cery, Prilly Lausanne, Switzerland)
I.R. Edwards (Uppsala Monitoring Centre, Uppsala, Sweden)
M.F. Fromm (Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany)
S.G. Kim (Seoul National University, Seoul, South Korea)
T. Kosoglou (Schering-Plough Research Institute, Kenilworth, NJ, USA)
L. Kritharides (University of Sydney, Sydney, Australia)
V. Kukongviriyapan (Khon Kaen University, Khon Kaen, Thailand)
I.L. Kuppens (University Hospital Maastricht, Maastricht, The Netherlands)
D.R.J. Kuypers (University of Leuven, Leuven, Belgium)
F. Labrie (Laval University, Quebec, Canada)
V.L. Lanchote (University of Sao Paulo, Sao Paulo, Brazil)
C.C. Lang (Ninewells Hospital and Medical School, Dundee, UK)
K.C. Lasseter (Clinical Pharmacology Associates, Miami, FL, USA)
V. Laurian (University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania)
F. Lavorini (University of Florence, Florence, Italy)
C.R. Lee (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA)
M.G. Lee (Seoul National University, Seoul, South Korea)
S.-E. Leucuta (Univ. of Med. and Pharm. "Iuliu Hatieganu", Cluj-Napoca, Romania)
Y. Leykin (Santa Maria degli Angeli Hospital, Pordenone, Italy)
J. Lima (Nemours Children's Clinic, Jacksonville, FL, USA)
A. LLerena (University of Extremadura, Badajoz, Spain)
F. Locatelli (A. Manzoni Hospital, Lecco, Italy)
A.W. Lyon (University of Calgary, Alberta, Canada)
Y. Maitani (Hoshi University, Tokyo, Japan)
T. Makino (Nagoya City University, Nagoya, Japan)
W.J. Malaisse (Brussels Free University, Brussels, Belgium)
H. Malonne (University Libre de Bruxelles, Bruxelles, Belgium)
A.A. Mangoni (Flinders University, Adelaide, Australia)
J.G. Maring (Diaconessen Hospital Meppel, Meppel, The Netherlands)
P.D. Martin (AstraZeneca, Cheshire, UK)
A. Marzo (IPAS SA, Ligornetto, Switzerland)
P.S. Masand (Duke University Medical Center, Durham, NC, USA)
Y. Matsumura (National Cancer Center Research Institute East, Kashiwa, Japan)
S.J. Matthews (Northeastern University, Boston, MA, USA)
P.M.J. McSheehy (Novartis Institute for Biomedical Research, Basel, Switzerland)
R. Mehvar (Texas Technical School of Pharmacy, Amarillo, TX, USA)
J.J. Meier (UCLA School of Medicine, Los Angeles, CA, USA)
I. Schumacher (Research and Quality Control Laboratory, Medical Corps, IDF, Israel)
A.K. Tiwari (Pharmacology and Systems Therapeutics, Mount Sinai School of
Medicine, New York 10029, USA)
R. Venkataramanan (University of Pittsburgh, Pittsburgh, USA)
T.N. Wise (Johns Hopkins Univ. Sch. of Med., Falls Church, VA, USA)